Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3

来源 :华中科技大学学报(医学英德文版) | 被引量 : 0次 | 上传用户:xds24
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Filamin A and 14-3-3-σ are closely associated with the development of breast cancer.However,the exact relationship between them is still unknown.The present study aimed to examine the interaction of filamin A with 14-3-3-σ in the invasion and migration of breast cancer.RNA interference technology was employed to silence filamin A in MDA-MB-231 cells.Real-time PCR and West blotting were used to detect the expression of filamin A and 14-3-3-σ at mRNA and protein levels,respectively.Double immunofluorescence was applied to show their colocalization morphologically.Wound healing assay and Trans-well assay were used to testify the migration and invasion of MDA-MB-231 cells in filamin A-silenced cells.The results showed that silencing filamin A significantly increased the mRNA and protein levels of 14-3-3σ.In addition,double immunofluorescence displayed that filamin A and 14-3-3σ were predominantly colocalized in the cytoplasm of MDA-MB-231 cells.Silencing filamin A led to the enhanced fluorescence of 14-3-3σ.Furthermore,cell functional experiments showed that silencing filamin A inhibited the migration and invasion of MDA-MB-231 cells in vitro.In conclusion,silencing filamin A may inhibit the invasion and migration of breast cancer cells by upregulating 14-3-3σ.
其他文献
目的 调查皮下注射精蛋白生物合成人胰岛素(预混30R)(以下简称“诺和灵30R”)的糖尿病患者皮下注射相关知识了解现状,分析存在问题及处理对策.方法 采取便利取样方法,采用自
期刊
目的 观察pN0期非小细胞肺癌(NSCLC)伴淋巴结微转移的病理特征,探讨其危险因素.方法 纳入117例pN0期NSCLC患者,检测淋巴结微转移情况、血清同型半胱氨酸(Hcy)及胱抑素C(CysC)
不明原因发热为临床疑难病症,现代医学各种检查多无明显异常,难以明确诊断,病情缠绵难愈.李家庚教授为我校名医名师,对于此类疾病有独到见解,临证多年,多以热毒未清,气阴两伤
如今,越来越多的人患上糖尿病,并且随着社会的逐渐老龄化,老年人患糖尿病的比例也在逐年上升,可以说糖尿病已经成为老年人的多发病、常见病,是老年人面临的主要健康问题.rn“
患者女性,63岁.rn主诉rn反复口干、多饮、多尿10年,多关节肿痛6年.rn现病史rn患者于10年前无明显诱因出现口干、多饮、多尿,遂到陆丰当地医院就诊,查随机血糖16+mmol/L,诊断
目的 探讨低频重复经颅磁刺激(rTMS)联合度洛西汀在首发抑郁症患者各期相的疗效与安全性.方法 选取某专科医院收治的首发抑郁患者168例,随机分为对照组和观察组,对照组予度洛
The serological markers are increasingly used in diagnosis of inflammatory bowel disease (IBD).D-lactate and diamine oxidase are new indicators that can be used
中国到底有多少糖尿病患者?rn“2013年中国卫生部门给出的数字是1.14亿,五年前的数字是9200万.四年间,中国多了2200万糖尿病患者,平均每年增长550万例,每天增长1.5万例,每小
患者肖某,女,55岁,职员.rn主诉rn口渴多饮8年,视力下降、下肢麻凉5年,加重2天.rn现病史rn患者8年前出现口渴多饮,就诊于某院发现血糖增高,空腹血糖11 mmol/1,餐后两小时血糖1
目的 分析孟鲁司特钠联合沙美特罗替卡松粉吸入剂治疗哮喘的临床疗效.方法 选择于2018年1月至2018年12月间收治的哮喘患者一般数据进行整理探讨,按照实验要求随机挑选106例患